Literature DB >> 19709461

The role of interleukin-6 in the formation of the coronary vasculature.

Indroneal Banerjee1, John W Fuseler, Colby A Souders, Stephanie L K Bowers, Troy A Baudino.   

Abstract

The formation and the patterning of the coronary vasculature are critical to the development and pathology of the heart. Alterations in cytokine signaling and biomechanical load can alter the vascular distribution of the vessels within the heart. Changes in the physical patterning of the vasculature can have significant impacts on the relationships of the pressure-flow network and distribution of critical growth and survival factors to the tissue. Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates several biological processes, including vasculogenesis. Using both immunohistological and cardioangiographic analyses, we tested the hypothesis that IL-6-loss will result in decreased vessel density, along with changes in vascular distribution. Moreover, given the impact of vascular patterning on pressure-flow and distribution mechanics, we utilized non-Euclidean geometrical fractal analysis to quantify the changes in patterning resulting from IL-6-loss. Our analyses revealed that IL-6-loss results in a decreased capillary density and increase in intercapillary distances, but does not alter vessel size or diameter. We also observed that the IL-6-/- coronary vasculature had a marked increase in fractal dimension (D value), indicating that IL-6-loss alters vascular patterning. Characterization of IL-6-loss on coronary vasculature may lend insight into the role of IL-6 in the formation and patterning of the vascular bed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709461      PMCID: PMC2854414          DOI: 10.1017/S1431927609990353

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  29 in total

1.  Fractal and image analysis of morphological changes in the actin cytoskeleton of neonatal cardiac fibroblasts in response to mechanical stretch.

Authors:  John W Fuseler; Clarke F Millette; Jeffery M Davis; Wayne Carver
Journal:  Microsc Microanal       Date:  2007-04       Impact factor: 4.127

2.  Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.

Authors:  I Friehs; R E Margossian; A M Moran; H Cao-Danh; M A Moses; P J del Nido
Journal:  Basic Res Cardiol       Date:  2005-12-23       Impact factor: 17.165

3.  Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.

Authors:  Yasuo Adachi; Chieko Aoki; Naoko Yoshio-Hoshino; Koichi Takayama; David T Curiel; Norihiro Nishimoto
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

4.  Regulation of NF-kappaB activation and nuclear translocation by exogenous nitric oxide (NO) donors in TNF-alpha activated vascular endothelial cells.

Authors:  Jennifer A Rogers; John W Fuseler
Journal:  Nitric Oxide       Date:  2007-02-15       Impact factor: 4.427

5.  Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.

Authors:  Ingeborg Friehs; Rodrigo Barillas; Nikolay V Vasilyev; Nathalie Roy; Francis X McGowan; Pedro J del Nido
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.

Authors:  Yasuhiro Izumiya; Ichiro Shiojima; Kaori Sato; Douglas B Sawyer; Wilson S Colucci; Kenneth Walsh
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

7.  Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis.

Authors:  Kenichi Matsushita; Shiro Iwanaga; Takahiro Oda; Kensuke Kimura; Megumi Shimada; Makoto Sano; Akihiro Umezawa; Jun-ichi Hata; Satoshi Ogawa
Journal:  Lab Invest       Date:  2005-10       Impact factor: 5.662

8.  The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.

Authors:  Rudolf Karch; Friederike Neumann; Robert Ullrich; Josef Neumüller; Bruno K Podesser; Martin Neumann; Wolfgang Schreiner
Journal:  Cardiovasc Pathol       Date:  2005 May-Jun       Impact factor: 2.185

9.  Analysis and quantitation of NF-kappaB nuclear translocation in tumor necrosis factor alpha (TNF-alpha) activated vascular endothelial cells.

Authors:  John W Fuseler; Dana M Merrill; Jennifer A Rogers; Matthew B Grisham; Robert E Wolf
Journal:  Microsc Microanal       Date:  2006-06       Impact factor: 4.127

10.  IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells.

Authors:  Louis W Feurino; Yuqing Zhang; Uddalak Bharadwaj; Rongxin Zhang; Fei Li; William E Fisher; F Charles Brunicardi; Changyi Chen; Qizhi Yao; L Min
Journal:  Cancer Biol Ther       Date:  2007-07       Impact factor: 4.742

View more
  4 in total

1.  c-Myc is required for proper coronary vascular formation via cell- and gene-specific signaling.

Authors:  Colby A Souders; Stephanie L K Bowers; Indroneal Banerjee; John W Fuseler; Jennifer L Demieville; Troy A Baudino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

Review 2.  Dynamic interactions between the cellular components of the heart and the extracellular matrix.

Authors:  Thomas K Borg; Troy A Baudino
Journal:  Pflugers Arch       Date:  2011-03-12       Impact factor: 3.657

Review 3.  Extracellular matrix roles during cardiac repair.

Authors:  Claude Jourdan-Lesaux; Jianhua Zhang; Merry L Lindsey
Journal:  Life Sci       Date:  2010-07-27       Impact factor: 5.037

Review 4.  Cardiac myocyte-fibroblast interactions and the coronary vasculature.

Authors:  Stephanie L K Bowers; Troy A Baudino
Journal:  J Cardiovasc Transl Res       Date:  2012-09-18       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.